DAWN MCCAFFERY: Open Payments
NPI 1568556074 · INDEPENDENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 30 payments from 6 companies in 2025. Trend: 2023 $401 · 2024 $433 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $102 |
| Novo Nordisk Inc | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
| Exact Sciences Corporation | 2 | $29 |
| Lilly USA, LLC | 1 | $14 |
Products named: QULIPTA, AIRSUPRA, VRAYLAR, Wegovy, CAPLYTA, UBRELVY, Cologuard Collection Kit, BREZTRI.
Industry payments across KS — which companies pay providers there.
